DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Anglesio MS, Arnold JM, George J et al.
Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous
activation of RAS-MAPK in ovarian serous low malignant potential tumors.
Mol Cancer Res 2008;
6: 1678-1690
Access:
We do not assume any responsibility for the contents of the web pages of other providers.